Clinical Trial Update: Percutaneous Holmium Injection in Pancreatic Cancer [NA]

View source ↗

Summary

This clinical trial update concerns percutaneous holmium injection for pancreatic cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Pancreas Cancer | NA | Status: ACTIVE_NOT_RECRUITING